Literature DB >> 33113068

Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.

Hiroyuki Kamide1, Shingo Kato2,3, Keigo Hayakawa4, Kazuki Fukui4, Hideya Kitamura5, Takashi Ogura5, Tae Iwasawa6, Kazuo Kimura7, Kouichi Tamura8, Daisuke Utsunomiya1.   

Abstract

OBJECTIVES: The aims of this study were to investigate the relationship between pulmonary hypertension (PH) and right ventricular (RV) strain, and to evaluate the prognostic value of RV strain by cardiac magnetic resonance (CMR) feature tracking for patients with interstitial lung disease (ILD).
METHODS: A total of seventy ILD patients (mean age: 71 ± 8 years, 39 [56%] males) who underwent CMR and right heart catheterization (RHC) were studied. Using a 1.5T magnetic resonance (MR) scanner, steady-state free precession cine MR images encompassing the RV were acquired in all patients and 20 control subjects. RV longitudinal strain were calculated with a feature tracking algorithm. PH was defined as a mean pulmonary artery pressure of more than 20 mmHg at rest and a pulmonary vascular resistance ≥3 Woods unit.
RESULTS: The RV longitudinal strain was significantly impaired in the ILD patients with PH (n=18) than ILD patients without PH (n=52) (-13.3 ± 5.4% vs. -16.9±5.4%, p=0.048). The RV longitudinal strain differed significantly between the ILD patients without PH and the controls (n=20) (-16.9 ± 5.4% vs. -20.8 ± 6.2%, p=0.002). Five of 70 (7%) patients died within one-year after CMR scan. Area under receiver operating characteristics curve for predicting death was 0.900 (95%CI: 0.800 to 1.000) for RV strain, 0.643 (95%CI: 0.454 to 0.832) for RVEF.
CONCLUSIONS: Presence of PH was associated with impairment of RV strain, and RV strain could predict short-term mortality in patients with ILD. RV strain by feature tracking might be useful as a non-invasive prognostic marker for patients with ILD.

Entities:  

Keywords:  Interstitial lung diseases; Magnetic resonance; Pulmonary hypertension

Mesh:

Year:  2020        PMID: 33113068     DOI: 10.1007/s10554-020-02079-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  33 in total

1.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  Christopher J Lettieri; Steven D Nathan; Scott D Barnett; Shahzad Ahmad; Andrew F Shorr
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

2.  British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.

Authors:  Robin M Rudd; Robin J Prescott; J C Chalmers; Ian D A Johnston
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

Review 3.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.

Authors:  R J Panos; R L Mortenson; S A Niccoli; T E King
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

4.  Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance.

Authors:  Alicia M Maceira; Sanjay K Prasad; Mohammed Khan; Dudley J Pennell
Journal:  Eur Heart J       Date:  2006-11-06       Impact factor: 29.983

Review 5.  Pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Nina M Patel; David J Lederer; Alain C Borczuk; Steven M Kawut
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

Review 6.  Cardiac manifestations of idiopathic pulmonary fibrosis.

Authors:  Abhinav Agrawal; Isha Verma; Varun Shah; Abhishek Agarwal; Rutuja R Sikachi
Journal:  Intractable Rare Dis Res       Date:  2016-05

7.  A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients.

Authors:  Takehiko Araki; Hideki Katsura; Motoji Sawabe; Kozui Kida
Journal:  Intern Med       Date:  2003-06       Impact factor: 1.271

8.  Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis.

Authors:  C E Daniels; E S Yi; J H Ryu
Journal:  Eur Respir J       Date:  2008-02-06       Impact factor: 16.671

9.  Association of Cardiovascular Disease With Respiratory Disease.

Authors:  Paul Carter; Jakub Lagan; Christien Fortune; Deepak L Bhatt; Jørgen Vestbo; Robert Niven; Nazia Chaudhuri; Erik B Schelbert; Rahul Potluri; Christopher A Miller
Journal:  J Am Coll Cardiol       Date:  2019-03-04       Impact factor: 24.094

10.  Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.

Authors:  Andrew J Swift; Smitha Rajaram; Michael J Campbell; Judith Hurdman; Steve Thomas; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.